Clinical data, not Genomics, Leading the Advent of Big Data in the Life Sciences

By Dr. Alan S. Louie – April 7, 2014
Photo of Dr. Alan S. LouieOffline

While the achievement of the $1000 genome will surely bring forth a tidal wave of new WGS data in the next 3-5 years, mountains of newly available data from completed clinical trials (likely via the Pfizer Clinical Cloud approach), related clinical trial transparency initiatives, and EMR data will likely be the near term focus of life science big data activities over the near term.


About the author

Dr. Alan S. Louie

Research DirectorIDC Health Insights

Dr. Alan Louie is Research Director at IDC Health Insights. In this role, he is spearheading the company’s research covering innovation and best practices in pharmaceutical R&D and personalized…

1 Comment

Photo of Steve ConwayOffline Steve Conway said 4 years ago

Post a comment

Form Signatures

Viewed 7,205 times